Where does Eutropics Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Eutropics Pharmaceuticals, Inc. ranks #24,302 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Eutropics Pharmaceuticals, Inc. hold?

Eutropics Pharmaceuticals, Inc. holds 11 US utility patents granted between 2015 and 2023, spanning 10 technology areas.

What is Eutropics Pharmaceuticals, Inc.'s Innovation Score?

Eutropics Pharmaceuticals, Inc. has an Innovation Score of 28.5 out of 100 (top 72% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Eutropics Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Eutropics Pharmaceuticals, Inc.'s recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Eutropics Pharmaceuticals, Inc.'s patents?

Eutropics Pharmaceuticals, Inc.'s patents average 12.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Eutropics Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Eutropics Pharmaceuticals, Inc.

Q: What technology areas does Eutropics Pharmaceuticals, Inc. focus on?

Eutropics Pharmaceuticals, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 8 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Eutropics ranks #24,302 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.

#24,302
of 50,000 US assignees by volume: Top 72%
by Innovation Score (28.5/100): 12.4
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24302 · US Corporation #24,302 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,302/50,000
PHOTO-FINISH Erwin Junker Maschin…
CPC-FOCUS A61K · 10 areas
INNOV-THIN 28.5/100
CLAIMS-RICH 12.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Erwin Junker Maschinenfabrik Gmbh (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Eutropics Pharmaceut… · this assignee

29
3D Lighting Innovati… · lowest

7

What this shows Eutropics's Innovation Score is 28.5/100 (top 72% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Eutropics's grants concentrate

Eutropics Pharmaceuticals, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 72.7% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2019. By volume, Eutropics sits between Erwin Junker Maschinenfabrik Gmbh and Exinda Networks PTY, Ltd..

Eutropics's three-year grant acceleration

Eutropics Pharmaceuticals, Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Erwin Junker Masc…

11
Esdec B V

11
Eseye

11
Estetra SPRL

11
Everpro

11
Everbridge

11
Evolv

11
Exinda Networks P…

11
Eutropics Pharmac… ◀

11

What this shows Eutropics holds 11 patents at rank #24,302, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Eutropics

By rank, the assignees closest to #24,302 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Eutropics's primary technology class.

Eutropics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 Top 72% higher than 28% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Eutropics Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2016	3	27.3%
2019	1	9.1%
2020	4	36.4%
2023	1	9.1%

Which technologies does Eutropics Pharmaceuticals, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 8

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 6

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5

C07D - HETEROCYCLIC COMPOUNDS 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 2

C07K - PEPTIDES 2

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#24,302

of 50,000 tracked assignees

Innovation Score

28.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.